HERP1 inhibits myocardin-induced vascular smooth muscle cell differentiation by interfering with SRF binding to CArG box
about
Olfactomedin 2, a novel regulator for transforming growth factor-β-induced smooth muscle differentiation of human embryonic stem cell-derived mesenchymal cellsHairy-related transcription factors inhibit Notch-induced smooth muscle alpha-actin expression by interfering with Notch intracellular domain/CBF-1 complex interaction with the CBF-1-binding siteEndothelial expression of the Notch ligand Jagged1 is required for vascular smooth muscle developmentThymine DNA glycosylase represses myocardin-induced smooth muscle cell differentiation by competing with serum response factor for myocardin bindingBone morphogenetic protein-induced MSX1 and MSX2 inhibit myocardin-dependent smooth muscle gene transcriptionMyocardin is differentially required for the development of smooth muscle cells and cardiomyocytesHistone deacetylase activity selectively regulates notch-mediated smooth muscle differentiation in human vascular cells.Sp1-dependent activation of KLF4 is required for PDGF-BB-induced phenotypic modulation of smooth muscle.Local delivery of the KCa3.1 blocker, TRAM-34, prevents acute angioplasty-induced coronary smooth muscle phenotypic modulation and limits stenosis.Multiple repressor pathways contribute to phenotypic switching of vascular smooth muscle cells.Modulation of myocardin function by the ubiquitin E3 ligase UBR5.Notch and transforming growth factor-beta (TGFbeta) signaling pathways cooperatively regulate vascular smooth muscle cell differentiation.MicroRNAs dynamically remodel gastrointestinal smooth muscle cellsExpression of Foxm1 transcription factor in cardiomyocytes is required for myocardial development.Molecular regulation of contractile smooth muscle cell phenotype: implications for vascular tissue engineering.Notch signaling change in pulmonary vascular remodeling in rats with pulmonary hypertension and its implication for therapeutic intervention.An essential role for Notch in neural crest during cardiovascular development and smooth muscle differentiation.Embryonic stem cell differentiation into smooth muscle cells is mediated by Nox4-produced H2O2.Alcohol and cardiovascular disease--modulation of vascular cell function.Alcohol inhibits smooth muscle cell proliferation via regulation of the Notch signaling pathwayVascular smooth muscle progenitor cells: building and repairing blood vessels.Elongation of Long-Chain Fatty Acid Family Member 6 (Elovl6)-Driven Fatty Acid Metabolism Regulates Vascular Smooth Muscle Cell Phenotype Through AMP-Activated Protein Kinase/Krüppel-Like Factor 4 (AMPK/KLF4) SignalingAutoregulatory Control of Smooth Muscle Myosin Light Chain Kinase Promoter by Notch Signaling.Notch transcriptional control of vascular smooth muscle regulatory gene expression and function.Delta-Notch--and then? Protein interactions and proposed modes of repression by Hes and Hey bHLH factorsNotch signaling in the vasculatureNuclear factor of activated T cells c1 mediates p21-activated kinase 1 activation in the modulation of chemokine-induced human aortic smooth muscle cell F-actin stress fiber formation, migration, and proliferation and injury-induced vascular wall reInterferon regulatory factor 8 modulates phenotypic switching of smooth muscle cells by regulating the activity of myocardin.Arp5 is a key regulator of myocardin in smooth muscle cellsSignaling mechanisms that regulate smooth muscle cell differentiation.Molecular pathways of notch signaling in vascular smooth muscle cells.Transgelins, cytoskeletal proteins implicated in different aspects of cancer development.Smooth Muscle Cell Differentiation: Model Systems, Regulatory Mechanisms, and Vascular Diseases.Mesenchymal stem cells and vascular regeneration.Notch Signaling in Vascular Smooth Muscle Cells.Notch signaling pathway enhances bone morphogenetic protein 2 (BMP2) responsiveness of Msx2 gene to induce osteogenic differentiation and mineralization of vascular smooth muscle cellsFrequent epigenetic inactivation of Myocardin in human nasopharyngeal carcinoma.Regulation of MMP10 expression by the transcription factor CHF1/Hey2 is mediated by multiple E boxes.Repression of smooth muscle differentiation by a novel high mobility group box-containing protein, HMG2L1.Runx2 represses myocardin-mediated differentiation and facilitates osteogenic conversion of vascular smooth muscle cells.
P2860
Q24305366-97358376-FE15-4FD8-8FE7-8E42749F38EFQ24309221-A3421E1F-A68C-4EE7-B797-CA1C732AC12EQ28267098-15294B18-C6E3-45EF-88AC-5122729CAE37Q28581191-C751E74A-210C-4B59-9E13-EF8ABB82E96CQ28589105-4567D54A-86CD-4F86-9083-85BBD32E01A1Q29347238-953F4CAD-26C1-40FD-84A6-50962A9E353FQ30424133-CB3BFB51-4BE4-45BB-8489-465C5D879FF0Q30436555-C362AC2E-354C-47DC-9BFB-7429600125D7Q30440082-73308F8A-2D2E-4BE8-86F8-92601CA0B6ACQ30441514-C3530373-8E69-4B7F-BC16-7F8BCFEB0830Q33782403-56E67A48-C3FE-4A3A-9743-C36E748CF3C2Q33885162-A8B60BA2-1F0B-4418-ADF8-9FCB56FE1992Q33886565-9AFF69A8-2D7D-4662-A661-BCCB5938619AQ33968310-9E5861B6-CF6D-4CE7-B12C-5010B0C8067FQ34146262-CC36C62E-900C-492C-BB44-2F370901128FQ34516783-E08CAC98-1665-433C-A6E5-D3A231B47B50Q34608845-106846CA-34C3-4DAD-9B1E-8F9420163517Q34889421-A068FF21-7EC2-4905-831F-3F4A55E17990Q35942603-0F56DAD4-758A-462F-B124-35E445B093AEQ36021912-317DF1AF-EE99-449C-A36E-8AE3F7338965Q36055604-C19C5CEC-EE22-4431-87D3-10D65ACFE7EFQ36203076-623BDF9D-B197-4BB4-94E1-016FD5BA4A41Q36548425-406C32D4-6D6D-4097-B8D6-A0FB9A44D9B9Q36779521-6B603F20-5AE2-4259-8AA7-80801A99C5FCQ36857288-D3581B89-909B-45C6-8517-96CDD892C773Q36861805-962A623D-AD2F-4778-B372-B2C2C7A26371Q37048514-FE12EFA1-9E23-43ED-9E25-344A12FEE831Q37546984-847365DD-320E-4EC4-A4D5-D0EC465C224AQ37614849-3305D94F-6600-4C6C-B0D4-A82F0510A77BQ37890184-3FC25B7F-6DE0-416F-B59A-FC4F65B47C2FQ38003146-4FFFAA70-DDFE-476C-B766-F756AD92C3D9Q38183143-2F038ACD-A324-4C05-AEBC-18F734295BDEQ38596550-9540100F-6A04-49C4-9520-3D2AEAD0924FQ38816740-F126C982-AE88-492E-85AE-10964E984F70Q39141059-6DA9C475-FE5C-408C-AEC9-643697B21D3FQ39563180-1BF7FBB1-5D9F-4FD8-BF50-AB0C033D1EC0Q39654774-3F293D83-A142-4638-BBCA-AA60F2AF28CCQ39673967-BFD42E22-2877-4731-97B1-EE319532C3B5Q39698789-E22DDF51-8CB5-4AFB-96D8-5779BE2C17B7Q40044363-703830E8-65C0-42AB-A3B9-86D51BDDB8D8
P2860
HERP1 inhibits myocardin-induced vascular smooth muscle cell differentiation by interfering with SRF binding to CArG box
description
2005 nî lūn-bûn
@nan
2005 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
HERP1 inhibits myocardin-induc ...... g with SRF binding to CArG box
@ast
HERP1 inhibits myocardin-induc ...... g with SRF binding to CArG box
@en
HERP1 inhibits myocardin-induc ...... g with SRF binding to CArG box
@nl
type
label
HERP1 inhibits myocardin-induc ...... g with SRF binding to CArG box
@ast
HERP1 inhibits myocardin-induc ...... g with SRF binding to CArG box
@en
HERP1 inhibits myocardin-induc ...... g with SRF binding to CArG box
@nl
prefLabel
HERP1 inhibits myocardin-induc ...... g with SRF binding to CArG box
@ast
HERP1 inhibits myocardin-induc ...... g with SRF binding to CArG box
@en
HERP1 inhibits myocardin-induc ...... g with SRF binding to CArG box
@nl
P2093
P1476
HERP1 inhibits myocardin-induc ...... g with SRF binding to CArG box
@en
P2093
Ei-ichi Okamoto
Hideo Akiyama
Hiroko Sato
Hiroshi Doi
Hiroyoshi Kanai
Keiko Kawai-Kowase
Larry Kedes
Masahiko Kurabayashi
Masashi Arai
Miki Yamazaki
P304
P356
10.1161/01.ATV.0000185829.47163.32
P407
P577
2005-11-01T00:00:00Z